Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of MX9307718ApublicationCriticalpatent/MX9307718A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Los nuevos compuestos de la fórmula ( ver fórmula I) en donde R1-R8, X, Y y n tienen el significado dado en la descripción, son inhibidores de receptores de endotelin y pueden utilizarse para el tratamiento de trastornos asociados con procedimientos que aumentan vasoconstricción.The new compounds of the formula (see formula I) where R1-R8, X, Y and n have the meaning given in the description, are endotelin receptor inhibitors and can be used for the treatment of disorders associated with procedures that increase vasoconstriction.
MX9307718A1992-12-101993-12-07
NEW SULPHONAMIDES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM.
MX9307718A
(en)
INDOL-3-GLIOXILAMIDAS N-SUBSTITUTED WITH ANTI-ASMATIC, ANTI-ALLERGIC AND IMMUNOSUPPRESSOR / IMMUNOMODULATOR EFFECTS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL STRUCTURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
AROMATIC POLYCLIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM.